NantHealth (NASDAQ:NH) Receives New Coverage From Analysts at StockNews.com
NantHealth (NASDAQ:NH) Receives New Coverage From Analysts at StockNews.com
StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report published on Saturday. The firm issued a hold rating on the stock.
StockNews.com 开始报道的股票 NantHealth（纳斯达克股票代码：NH — 获取评级） 在周六发布的一份报告中。该公司对该股发布了持有评级。
NantHealth Stock Down 5.0 %
NanHealth 股票下跌 5.0%
Shares of NH opened at $1.51 on Friday. The company has a market cap of $11.63 million, a PE ratio of -0.20 and a beta of 1.83. The business has a fifty day moving average of $2.25 and a 200 day moving average of $1.96. NantHealth has a 52-week low of $1.24 and a 52-week high of $11.85.
NH的股票周五开盘价为1.51美元。该公司的市值为1163万美元，市盈率为-0.20，beta值为1.83。该公司的五十天移动平均线为2.25美元，200天移动平均线为1.96美元。NantHealth创下52周低点1.24美元，创52周高点11.85美元。
Institutional Trading of NantHealth
nanHealth 的机构交易
A number of hedge funds and other institutional investors have recently bought and sold shares of NH. Goldman Sachs Group Inc. purchased a new position in shares of NantHealth during the second quarter valued at $36,000. Millennium Management LLC purchased a new position in shares of NantHealth during the second quarter valued at $110,000. Finally, Atria Wealth Solutions Inc. purchased a new position in shares of NantHealth during the first quarter valued at $170,000. Hedge funds and other institutional investors own 4.50% of the company's stock.
一些对冲基金和其他机构投资者最近买入和卖出了NH的股票。高盛集团公司在第二季度购买了NanThealth股票的新头寸，价值36,000美元。千禧管理有限责任公司在第二季度收购了NanThealth股票的新头寸，价值11万美元。最后，Atria Wealth Solutions Inc.在第一季度购买了价值17万美元的NantHealth股票的新头寸。对冲基金和其他机构投资者拥有该公司4.50％的股票。
About NantHealth
关于 nanHealth
(Get Rating)
（获取评分）
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
NantHealth, Inc是一家基于证据的个性化医疗保健公司，致力于为癌症等关键疾病提供治疗。该公司支持治疗决策，改善患者预后，验证治疗方案，提供高质量的护理，降低成本，确保适当的报销，并简化实施和部署。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- United Parcel Service Delivers A Warning To The Market
- Pulte Homes Is Hosting The Better, More Profitable Open House
- Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal
- A Top Is In For McDonald's Corporation Stock
- Strong Demand Makes Cleveland-Cliffs an Undervalued Mid-Cap
- 免费获取 StockNews.com 关于 NantHealth（NH）的研究报告的副本
- 联合包裹服务向市场发出警告
- Pulte Homes正在举办更好、更有利可图的开放日
- Virios Therapeutics 因纤维肌痛第 3 阶段提案上涨了 75%
- 麦当劳公司股票将达到顶峰
- 强劲的需求使克利夫兰-克利夫斯成为被低估的中型股
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接收 NanHealth Daily 的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收NantHealth及相关公司最新新闻和分析师评级的简明每日摘要。